Home › Funds › Fideuram Asset Management (Ireland) dac › GILD

Fideuram Asset Management (Ireland) dac position in GILD

GILEAD SCIENCES INC · Health Care

Fideuram Asset Management (Ireland) dac reported holding 196,620 shares of GILD (GILEAD SCIENCES INC) in its Q3 2026 13F filing — a position valued at US$27.8M, representing 0.61% of its reported portfolio and ranking #23 among its reported holdings. Fideuram Asset Management (Ireland) dac has disclosed GILD holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)196.62K sh
Reported value held$27.80M
Portfolio Weight0.61%
First reportedQ4 2025
Last changeReduce
Updated2026-10-29

Last updated: 2026-10-29 · Source: SEC EDGAR Form 13F-HR

How Fideuram Asset Management (Ireland) dac's GILD position evolved

Fideuram Asset Management (Ireland) dac first disclosed a stake in GILD in Q4 2025 at 99,871 shares (US$12.0M). The position peaked in Q3 2026 at 196,620 shares, worth US$27.8M. Across 4 filings, Fideuram Asset Management (Ireland) dac increased the stake 1 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 196,620 shares valued at US$27.8M — a reduction of -5,302 shares quarter over quarter.. Notable position changes include a 95% trim in Q1 2026 (shares fell 10% over the following quarter), a 3630% increase in Q2 2026 (shares rose 18% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 99.87K $12.03M New
Q1 2026 5.41K $769.25K Reduce
Q2 2026 201.92K $26.53M Add
Q3 2026 196.62K $27.80M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GILD and 13F data

GILD (GILEAD SCIENCES INC) is a Health Care company. 35 other funds we track also report a position in GILD — the largest reported positions include Fidelity Management & Research (FMR) (US$8.45B), Capital World Investors (US$5.18B), Capital World Investors (US$5.18B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GILD

All GILD fund holders →

FAQ

How long has Fideuram Asset Management (Ireland) dac held GILD?

Fideuram Asset Management (Ireland) dac has disclosed GILD holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is Fideuram Asset Management (Ireland) dac's current position in GILD?

As of Q3 2026, Fideuram Asset Management (Ireland) dac holds 196.62K shares of GILD (GILEAD SCIENCES INC), valued at $27.80M, representing 0.61% of its reported portfolio and ranking #23.

Has Fideuram Asset Management (Ireland) dac been buying or selling GILD?

In the latest 13F filing (Q3 2026), Fideuram Asset Management (Ireland) dac reduced its position in GILD. The position peaked in Q3 2026 at 196.62K shares.

Which other funds hold GILD?

Other major institutional holders of GILD include Fidelity Management & Research (FMR), Capital World Investors, Capital World Investors, among 35 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.